drugset / Trial / NCT01679041

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

NCT01679041

Phase 2 Terminated 1 enrolled Seah Lim M.D.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the toxicity and the effectiveness of high dose chemotherapy with HPC transplant Multiple Sclerosis that has failed at least two lines of therapy

Timeline

Start
2012-11
Primary completion
2013-11
Completion
2013-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Alemtuzumab Monoclonal antibody 10 mg Intravenous
Background Cyclophosphamide Other / unclassified 50 mg/kg
Background Fludarabine Small molecule 25 mg/m2 Intravenous

Indications